Inventor · disambiguated record
Frank Burkamp
Also filed as: BURKAMP FRANK
20 granted patents·19 pending applications·89 citations·filing 2000–2023
93Inventor score
Files withALMAC DISCOVERY LTD14MERCK SHARP & DOHME6BURKAMP FRANK4ASTRAZENECA R & D3BONNERT ROGER VICTOR3
Top patents by PatentIndex Score
39 records- 0186US6852718B2Phenylsulphonylipiperazinyl derivatives as 5-HT receptor ligandsMERCK SHARP & DOHME·Filed 2001·Granted Feb 8, 2005·35 cites·7 claims
- 0284US11053213B2Pharmaceutical compoundsALMAC DISCOVERY LTD·Filed 2017·Granted Jul 6, 2021·5 cites·21 claims
- 0383US9850247B2Pyrimidopyrimidinones useful as Wee-1 kinase inhibitorsALMAC DISCOVERY LTD·Filed 2014·Granted Dec 26, 2017·5 cites·20 claims
- 0479US6559166B1Phenylsulphonyl derivatives as 5-HT receptor ligandsMERCK SHARP & DOHME·Filed 2000·Granted May 6, 2003·14 cites·7 claims
- 0577US10766903B2Piperidine derivatives as inhibitors of ubiquitin specific protease 7ALMAC DISCOVERY LTD·Filed 2017·Granted Sep 8, 2020·3 cites·22 claims
- 0675US11208413B2Pyrimidopyrimidinones useful as wee-1 kinase inhibitorsALMAC DISCOVERY LTD·Filed 2018·Granted Dec 28, 2021·1 cites·12 claims
- 0774US9221838B2Inhibitors of AKT activityZHANG LIXIN·Filed 2010·Granted Dec 29, 2015·4 cites·16 claims
- 0873US8163724B2Glucocorticosteroids, processes for their preparation, pharmaceutical compositions containing them and their use in therapyBLADH HAAKAN·Filed 2008·Granted Apr 24, 2012·4 cites·19 claims
- 0972US7442701B2Amino-heterocycles as VR-1 antagonists for treating painMERCK SHARP & DOHME·Filed 2003·Granted Oct 28, 2008·6 cites·10 claims
- 1069US9714244B2Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitorsALMAC DISCOVERY LTD·Filed 2014·Granted Jul 25, 2017·2 cites·11 claims
- 1168US9156853B2AKT inhibitor compounds for treatment of cancerALMAC DISCOVERY LTD·Filed 2013·Granted Oct 13, 2015·1 cites·23 claims
- 1267US11807646B24-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)ALMAC DISCOVERY LTD·Filed 2019·Granted Nov 7, 2023·1 cites·15 claims
- 1365US7449585B2Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1)MERCK SHARP & DOHME·Filed 2004·Granted Nov 11, 2008·2 cites·5 claims
- 1464US6777430B2Phenylsulphonyl derivatives as 5-HT receptor ligandsMERCK SHARP & DOHME·Filed 2003·Granted Aug 17, 2004·2 cites·9 claims
- 1563US8203004B2Tetrahydroindole derivatives for treatment of alzheimer's diseaseBURKAMP FRANK·Filed 2006·Granted Jun 19, 2012·1 cites·6 claims
- 1662US7329659B2Substituted-1-phthalazinamines as vr-1 antagonistsMERCK SHARP & DOHME·Filed 2004·Granted Feb 12, 2008·2 cites·8 claims
- 1761US12466805B2Pharmaceutical compoundsALMAC DISCOVERY LTD·Filed 2021·Granted Nov 11, 2025·0 cites·22 claims
- 1861US8546376B2Pharmaceutical compoundsBELL MARK PETER·Filed 2010·Granted Oct 1, 2013·1 cites·16 claims
- 1960US2022194947A1Pyrimidopyrimidinones useful as wee-1 kinase inhibitorsALMAC DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 2059US2010204203A1Chemical Compounds 637: Pyridopyrimidinediones as PDE4 InhibitorsBONNERT ROGER VICTOR·Filed 2008·Application pending·0 cites
- 2159US2009124596A1Chemical Compounds 637BONNERT ROGER VICTOR·Filed 2008·Application pending·0 cites
- 2256US2025122223A1Heterocyclic compounds as ubiquitin specific protease 7 inhibitorsALMAC DISCOVERY LTD·Filed 2023·Application pending·0 cites
- 2353US2024327382A1Pharmaceutical compounds as inhibitors of ubiquitin specific protease 19ALMAC DISCOVERY LTD·Filed 2022·Application pending·0 cites
- 2450US2012077801A1Chemical Compounds 637BONNERT ROGER VICTOR·Filed 2011·Application pending·0 cites
- 2548US2013237507A1Novel Amide CompoundsASTRAZENECA AB INTELLECTUAL PROPERTY·Filed 2013·Application pending·0 cites
- 2644US2006235021A1Phenylpyridazine derivatives as ligands for gaba receptorsBLACKABY WESLEY·Filed 2003·Application pending·0 cites
- 2743US2011294766A116 Alpha, 17 Alpha-Acetal Glucocorticosteroidal Derivatives and their UseBURKAMP FRANK·Filed 2009·Application pending·0 cites
- 2843US2007135423A1E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of painBAYLISS TRACY·Filed 2004·Application pending·0 cites
- 2941US2010256104A1Novel amide compoundsASTRAZENECA R & D·Filed 2010·Application pending·0 cites
- 3041US2006154930A1Substituted amino heterocycles as vr-1 antagonists for treating painBROWN REBECCA E·Filed 2004·Application pending·0 cites
- 3141US2022016115A1Usp19 inhibitors for use in therapyALMAC DISCOVERY LTD·Filed 2019·Application pending·0 cites
- 3240US2012178726A1Novel compoundsBLADH HAAKAN·Filed 2012·Application pending·0 cites
- 3340US2008300261A1Arylacetic Acids and Related Compounds for Treatment of Alzheimer's DiseaseBLURTON PETER·Filed 2005·Application pending·0 cites
- 3439US2022033397A1Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)ALMAC DISCOVERY LTD·Filed 2019·Application pending·0 cites
- 3537US8338587B2CompoundsBURKAMP FRANK·Filed 2010·Granted Dec 25, 2012·0 cites·7 claims
- 3637US2007213332A1Prodrugs Of Substituted Amino Heterobicycles Which Modulate The Function Of The Vanilloid-1 Receptor (Vr1)BURKAMP FRANK·Filed 2005·Application pending·0 cites
- 3736US10766902B2Wee-1 inhibiting pyrazolopyrimidinone compoundsALMAC DISCOVERY LTD·Filed 2017·Granted Sep 8, 2020·0 cites·26 claims
- 3835US2010256105A1Novel compoundsASTRAZENECA R & D·Filed 2010·Application pending·0 cites
- 3935US2010261690A1Novel combinationsASTRAZENECA R & D·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Burkamp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →